# Post-marketing Safety and Efficacy Surveillance of Motherwort Injection

> **NCT06636422** · — · UNKNOWN · sponsor: **Zhong Wang** · enrollment: 20000 (estimated)

## Conditions studied

- Bleeding
- Real-world Study
- Adverse Events

## Interventions

- **DRUG:** Motherwort injection

## Key facts

- **NCT ID:** NCT06636422
- **Lead sponsor:** Zhong Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-10-15
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06636422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06636422, "Post-marketing Safety and Efficacy Surveillance of Motherwort Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06636422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
